Advertisement

Endocrine

, Volume 66, Issue 3, pp 682–690 | Cite as

Risk factors for vertebral fracture in primary hyperparathyroidism

  • Minghao Liu
  • John Williams
  • Jennifer Kuo
  • James A. Lee
  • Shonni J. Silverberg
  • Msarcella D. WalkerEmail author
Original Article

Abstract

Purpose

Screening for vertebral fractures (VF) in primary hyperparathyroidism (PHPT) is recommended, but there are limited data regarding which patients are at greatest risk for VF. We evaluated risk factors for VF in PHPT.

Methods

This is a retrospective cross-sectional analysis of 117 participants with PHPT. We assessed Grades 2 and 3 VF by vertebral fracture assessment (VFA) and the association of VF with the trabecular bone score (TBS), other skeletal parameters and clinical risk factors. VFA was performed only in those who met National Osteoporosis Foundation criteria for VFA screening.

Results

T-scores were in the osteopenic range and TBS was degraded. Overall VF rate based on VFA or other imaging was 12.8%. Serum PTH, calcium and TBS were not associated with VF. Those with VF were older (p = 0.04), had worse renal function (p = 0.04), were more likely to have received osteoporosis treatment (p = 0.03), and tended to have had a prior fracture (p = 0.06). T-scores did not differ by fracture status at any skeletal site. Those with VF had nine times the odds of osteoporosis at the hip (95% CI 2.4–34.5), but this risk factor had low sensitivity (46.7%) for VF. Hip T-score < −2.6, Age > 78.6 years, and GFR < 58.8 ml/min/1.73 m2 (thresholds maximizing sensitivity and specificity) had areas under the curve of 0.60–0.67 for VF (all p < 0.05) and low sensitivity. Findings were similar when analyses were limited to women.

Conclusions

In PHPT, VF risk factors included older age, prior fracture, worse renal function and osteoporosis at the hip, but not osteoporosis at other sites, TBS or biochemical indices of PHPT. Since identified risk factors had low sensitivity and were generally inaccurate for categorizing those with VF, the data do not support limiting screening to PHPT patients with these specific VF risk factors.

Keywords

Primary hyperparathyroidism Vertebral fractures TBS Prevalence 

Notes

Funding

This study was funded by the Endocrine Fellows Foundation, T32 DK007271.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

The Columbia University Medical Center Institutional Review Board granted a waiver of consent (45 CFR 46.116) for this study as this was a retrospective chart review of historical patients, the study involved no more than minimal risk to participants, the waiver did not adversely affect the rights and welfare of the subjects, and the research could not practicably be carried out without the waiver.

References

  1. 1.
    M.D. Walker, S.J. Silverberg, Primary hyperparathyroidism. Nat. Rev. Endocrinol. 14(2), 115–125 (2018)CrossRefGoogle Scholar
  2. 2.
    S.J. Silverberg, E. Shane, L. de la Cruz, D.W. Dempster, F. Feldman, D. Seldin et al. Skeletal disease in primary hyperparathyroidism. J. Bone Min. Res. 4(3), 283–291 (1989)CrossRefGoogle Scholar
  3. 3.
    M.D. Walker, E. Cong, J.A. Lee, A. Kepley, C. Zhang, D.J. McMahon et al. Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation. J. Clin. Endocrinol. Metab. 100(9), 3443–3451 (2015)CrossRefGoogle Scholar
  4. 4.
    S. De Geronimo, E. Romagnoli, D. Diacinti, E. D’Erasmo, S. Minisola, The risk of fractures in postmenopausal women with primary hyperparathyroidism. Eur. J. Endocrinol. 155(3), 415–420 (2006)CrossRefGoogle Scholar
  5. 5.
    A.M. Kenny, D.C. MacGillivray, C.C. Pilbeam, H.D. Crombie, L.G. Raisz, Fracture incidence in postmenopausal women with primary hyperparathyroidism. Surgery 118(1), 109–114 (1995)CrossRefGoogle Scholar
  6. 6.
    L.J. Melton III, E.J. Atkinson, W.M. O’Fallon, H. Heath III, Risk of age-related fractures in patients with primary hyperparathyroidism. Arch. Intern Med. 152(11), 2269–2273 (1992)CrossRefGoogle Scholar
  7. 7.
    E. Vignali, G. Viccica, D. Diacinti, F. Cetani, L. Cianferotti, E. Ambrogini et al. Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 94(7), 2306–2312 (2009)CrossRefGoogle Scholar
  8. 8.
    C. Eller-Vainicher, M. Filopanti, S. Palmieri, F.M. Ulivieri, V. Morelli, V.V. Zhukouskaya et al. Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism. Eur. J. Endocrinol. 169(2), 155–162 (2013)CrossRefGoogle Scholar
  9. 9.
    H. Kaji, M. Yamauchi, K. Chihara, T. Sugimoto, The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism. Eur. J. Endocrinol. 153(3), 373–378 (2005)CrossRefGoogle Scholar
  10. 10.
    C. Cipriani, F. Biamonte, A.G. Costa, C. Zhang, P. Biondi, D. Diacinti et al. Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. J. Clin. Endocrinol. Metab. 100(4), 1309–1315 (2015)CrossRefGoogle Scholar
  11. 11.
    S. Hansen, J.E. Beck Jensen, L. Rasmussen, E.M. Hauge, K. Brixen, Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: a case-control study using HR-pQCT. J. Bone Min. Res. 25(9), 1941–1947 (2010)CrossRefGoogle Scholar
  12. 12.
    E.M. Stein, B.C. Silva, S. Boutroy, B. Zhou, J. Wang, J. Udesky et al. Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women. J. Bone Min. Res. 28(5), 1029–1040 (2013)CrossRefGoogle Scholar
  13. 13.
    B.C. Silva, W.D. Leslie, H. Resch, O. Lamy, O. Lesnyak, N. Binkley et al. Trabecular Bone Score: A Noninvasive Analytical Method Based Upon the DXA Image. J. Bone Miner. Res. 29(3), 518–530 (2014)CrossRefGoogle Scholar
  14. 14.
    D. Hans, A.L. Goertzen, M.A. Krieg, W.D. Leslie, Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J. Bone Min. Res. 26(11), 2762–2769 (2011)CrossRefGoogle Scholar
  15. 15.
    S. Boutroy, D. Hans, E. Sornay-Rendu, N. Vilayphiou, R. Winzenrieth, R. Chapurlat, Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study. Osteoporos. Int. 24(1), 77–85 (2013)CrossRefGoogle Scholar
  16. 16.
    K. Briot, S. Paternotte, S. Kolta, R. Eastell, D.M. Reid, D. Felsenberg et al. Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: the OPUS study. Bone 57(1), 232–236 (2013)CrossRefGoogle Scholar
  17. 17.
    E. Romagnoli, C. Cipriani, I. Nofroni, C. Castro, M. Angelozzi, A. Scarpiello et al. “Trabecular Bone Score” (TBS): an indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism. Bone 53(1), 154–159 (2013)CrossRefGoogle Scholar
  18. 18.
    J.P. Bilezikian, M.L. Brandi, R. Eastell, S.J. Silverberg, R. Udelsman, C. Marcocci et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99(10), 3561–3569 (2014)CrossRefGoogle Scholar
  19. 19.
    F. Cosman, S.J. de Beur, M.S. LeBoff, E.M. Lewiecki, B. Tanner, S. Randall et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos. Int. 25(10), 2359–2381 (2014)CrossRefGoogle Scholar
  20. 20.
    D. Hans, N. Barthe, S. Boutroy, L. Pothuaud, R. Winzenrieth, M.A. Krieg, Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae. J. Clin. Densitom. 14(3), 302–312 (2011)CrossRefGoogle Scholar
  21. 21.
    H.K. Genant, C.Y. Wu, C. van Kuijk, M.C. Nevitt, Vertebral fracture assessment using a semiquantitative technique. J. Bone Min. Res. 8(9), 1137–1148 (1993)CrossRefGoogle Scholar
  22. 22.
    A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern Med. 130(6), 461–470 (1999)CrossRefGoogle Scholar
  23. 23.
    G. Ballane, J.A. Cauley, M.M. Luckey, G. El-Hajj Fuleihan, Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos. Int. 28(5), 1531–1542 (2017)CrossRefGoogle Scholar
  24. 24.
    J.T. Schousboe, Epidemiology of vertebral fractures. J. Clin. Densitom. 19(1), 8–22 (2016)CrossRefGoogle Scholar
  25. 25.
    J.T. Schousboe, T. Vo, B.C. Taylor, P.M. Cawthon, A.V. Schwartz, D.C. Bauer et al. Prediction of incident major osteoporotic and hip fractures by trabecular bone score (TBS) and prevalent radiographic vertebral fracture in older men. J. Bone Min. Res. 31(3), 690–697 (2016)CrossRefGoogle Scholar
  26. 26.
    L.J. Melton III, S.H. Kan, M.A. Frye, H.W. Wahner, W.M. O’Fallon, B.L. Riggs, Epidemiology of vertebral fractures in women. Am. J. Epidemiol. 129(5), 1000–1011 (1989)CrossRefGoogle Scholar
  27. 27.
    H. Ejlsmark-Svensson, L.S. Bislev, S. Lajlev, T. Harslof, L. Rolighed, T. Sikjaer et al. Prevalence and risk of vertebral fractures in primary hyperparathyroidism: a nested case-control study. J. Bone Min. Res. 33(9), 1657–1664 (2018)CrossRefGoogle Scholar
  28. 28.
    J.A. Cauley, L. Palermo, M. Vogt, K.E. Ensrud, S. Ewing, M. Hochberg et al. Prevalent vertebral fractures in black women and white women. J. Bone Min. Res. 23(9), 1458–1467 (2008)CrossRefGoogle Scholar
  29. 29.
    H.K. Genant, Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos. Int. 10(4), 259–264 (1999)CrossRefGoogle Scholar
  30. 30.
    E.M. Lewiecki, A.J. Laster, Clinical review: clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry. J. Clin. Endocrinol. Metab. 91(11), 4215–4222 (2006)CrossRefGoogle Scholar
  31. 31.
    B.A. Christiansen, M.L. Bouxsein, Biomechanics of vertebral fractures and the vertebral fracture cascade. Curr. Osteoporos. Rep. 8(4), 198–204 (2010)CrossRefGoogle Scholar
  32. 32.
    D.L. Kendler, D.C. Bauer, K.S. Davison, L. Dian, D.A. Hanley, S.T. Harris et al. Vertebral fractures: clinical importance and management. Am. J. Med. 129(2), 221, e1–10 (2016)CrossRefGoogle Scholar
  33. 33.
    J.T. Schousboe, C.R. Debold, Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice. Osteoporos. Int. 17(2), 281–289 (2006)CrossRefGoogle Scholar
  34. 34.
    P.D. Delmas, H.K. Genant, G.G. Crans, J.L. Stock, M. Wong, E. Siris et al. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone 33(4), 522–532 (2003)CrossRefGoogle Scholar
  35. 35.
    M. Iki, J. Tamaki, E. Kadowaki, Y. Sato, N. Dongmei, R. Winzenrieth et al. Trabecular bone score (TBS) predicts vertebral fractures in Japanese women over 10 years independently of bone density and prevalent vertebral deformity: the Japanese Population-Based Osteoporosis (JPOS) cohort study. J. Bone Min. Res. 29(2), 399–407 (2014)CrossRefGoogle Scholar
  36. 36.
    C. Cipriani, F. Biamonte, A.G. Costa, C. Zhang, P. Biondi, D. Diacinti et al. Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. J. Clin. Endocrinol. Metab. 100(4), 1309–1315 (2015)CrossRefGoogle Scholar
  37. 37.
    G. Viccica, F. Cetani, E. Vignali, M. Miccoli, C. Marcocci, Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism. Endocrine 55(1), 256–265 (2017)CrossRefGoogle Scholar
  38. 38.
    S. Waterloo, L.A. Ahmed, J.R. Center, J.A. Eisman, B. Morseth, N.D. Nguyen et al. Prevalence of vertebral fractures in women and men in the population-based Tromso Study. BMC Musculoskelet. Disord. 13, 3 (2012)CrossRefGoogle Scholar
  39. 39.
    M. Frost, K. Wraae, B. Abrahamsen, M. Hoiberg, C. Hagen, M. Andersen et al. Osteoporosis and vertebral fractures in men aged 60–74 years. Age Ageing 41(2), 171–177 (2012)CrossRefGoogle Scholar
  40. 40.
    E. Kanterewicz, E. Puigoriol, J. Garcia-Barrionuevo, L. del Rio, M. Casellas, P. Peris et al. Prevalence of vertebral fractures and minor vertebral deformities evaluated by DXA-assisted vertebral fracture assessment (VFA) in a population-based study of postmenopausal women: the FRODOS study. Osteoporos. Int. 25(5), 1455–1464 (2014)PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Endocrinology, Department of MedicineColumbia UniversityNew YorkUSA
  2. 2.Department of SurgeryColumbia UniversityNew YorkUSA

Personalised recommendations